Cargando…
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
This review summarizes state-of-the-art knowledge in early-generation and novel urine biomarkers targeting the telomerase pathway for the detection and follow-up of bladder cancer (BC). The limitations of the assays detecting telomerase reactivation are discussed and the potential of transcription-a...
Autores principales: | Zvereva, Maria, Pisarev, Eduard, Hosen, Ismail, Kisil, Olga, Matskeplishvili, Simon, Kubareva, Elena, Kamalov, David, Tivtikyan, Alexander, Manel, Arnaud, Vian, Emmanuel, Kamalov, Armais, Ecke, Thorsten, Calvez-Kelm, Florence Le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503716/ https://www.ncbi.nlm.nih.gov/pubmed/32839402 http://dx.doi.org/10.3390/ijms21176034 |
Ejemplares similares
-
Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study
por: Jain, Mark, et al.
Publicado: (2021) -
Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies
por: Jain, Mark, et al.
Publicado: (2023) -
Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
por: Hasanau, Tsimur, et al.
Publicado: (2022) -
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision
por: Ecke, Thorsten H., et al.
Publicado: (2022) -
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
por: Ecke, Thorsten H., et al.
Publicado: (2020)